Lindsay A Md Rosenwald Journey Medical Corp (DERM) insider trading activity

Lindsay A Md Rosenwald is Director of Journey Medical Corp. Currently has a direct ownership of 211,146 shares of DERM, which is worth approximately $1.6 Million. The most recent transaction as insider was on Aug 05, 2025, when has been sold 50,000 shares (Common Stock, $0.0001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 211K

37.13% 3M change

37.13% 12M change

Total Value Held $1.6 Million

LINDSAY A MD ROSENWALD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2025	BUY Grant, award, or other acquisition	-	50,000 Added 19.15%	211,146 Common Stock, $0.0001 ...
Jun 25 2025	BUY Grant, award, or other acquisition	-	7,173 Added 4.26%	161,146 Common Stock, $0.0001 ...
Jul 08 2024	BUY Grant, award, or other acquisition	-	9,728 Added 5.94%	153,973 Common Stock, $0.0001 ...
Mar 25 2024	BUY Open market or private purchase	$30,400 $3.04 p/Share	10,000 Added 6.48%	144,245 Common Stock, $0.0001 ...
Mar 22 2024	BUY Open market or private purchase	$68,000 $3.4 p/Share	20,000 Added 12.97%	134,245 Common Stock, $0.0001 ...
Sep 06 2023	BUY Open market or private purchase	$223,000 $2.23 p/Share	100,000 Added 46.68%	114,245 Common Stock, par valu...
Jul 21 2022	BUY Grant, award, or other acquisition	-	14,245 Added 50.0%	14,245 Common Stock, par valu...

Also insider at

CKPT

Checkpoint Therapeutics, Inc. Healthcare

Director

FBIO

Fortress Biotech, Inc. Healthcare

PRESIDENT, CEO & CHAIRMAN

MBIO

MUSTANG BIO, INC. Healthcare

Director

ATXI

AVENUE THERAPEUTICS, INC. Healthcare

Director

LAM